Business
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News
A study finds treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces…
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been…
Continue Reading
-
General24 hours agoTruck driver charged with causing death by dangerous driving after highway crash
-
Noosa News22 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News12 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General9 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for